Back to Search Start Over

GSK's ViiV gets USD1.25 billion from Gilead patent pact

GSK's ViiV gets USD1.25 billion from Gilead patent pact

Source :
Plus Company Updates. February 3, 2022
Publication Year :
2022

Abstract

London: GlaxoSmithKline PLC has issued the following press release: GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent infringement litigation with Gilead Sciences [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.692191897